SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-22-062792
Filing Date
2022-10-07
Accepted
2022-10-07 16:05:33
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea166822-s3_jaspertherap.htm S-3 426946
2 FORM OF INDENTURE ea166822ex4-3_jaspertherap.htm EX-4.3 323280
3 OPINION OF PAUL HASTINGS LLP ea166822ex5-1_jaspertherap.htm EX-5.1 41913
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea166822ex23-1_jaspertherap.htm EX-23.1 1570
5 FILING FEE TABLE ea166822ex-fee_jaspertherap.htm EX-FILING FEES 86829
6 GRAPHIC image_001.jpg GRAPHIC 2958
7 GRAPHIC image_002.jpg GRAPHIC 30711
8 GRAPHIC ex5-1_001.jpg GRAPHIC 8650
  Complete submission text file 0001213900-22-062792.txt   940319
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267777 | Film No.: 221300807
SIC: 2836 Biological Products, (No Diagnostic Substances)